2020

    1. Fallara G, Lissbrant IF, Styrke J, Montorsi F, Garmo H, Stattin P. Observational study on time on treatment with abiraterone and enzalutamide. PLoS One. 2020 Dec. Sammanfattning
    2. R Gedeborg, H Garmo, D Robinson, P Stattin. Prescription-based prediction of baseline mortality risk among older men. PLoS One 2020 Oct. Sammanfattning
    3. Parker J, Crawley D, Garmo H, Lindahl B, Styrke J, Adolfsson J, Lambe M, Stattin P, Van Hemelrijck M, Beckmann K. Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study. Front Oncol. 2020 Oct. Sammanfattning
    4. Casey C, Stattin P, Brooks J. D, Stocks T, Sundquist J, Sieh W, Sundquist K. Early-Life Cardiorespiratory Fitness and Long-term Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers Prev. 2020 Aug 20. Sammanfattning. 
    5. Jochems S H J, Stattin P, Häggström C, Järvholm B, Orho-Melander M, Wood A M, Stocks T. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category. Int J Cancer. 2020 Jun 11. Sammanfattning.
    6. Thurtle D, Bratt O, Stattin P, Pharoah P, Gnanapragasam V. Comparative Performance and External Validation of the Multivariable PREDICT Prostate Tool for Non-Metastatic Prostate Cancer: A Study in 69,206 Men From Prostate Cancer Data Base Sweden (PCBaSe). BMC Med 2020 Jun 16. Sammanfattning.
    7. Lycken M, Drevin L, Garmo H, et al. Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study. Scand J Urol 2020 May 31. Sammanfattning. 
    8. Lin E, Garmo H, Van Hemelrijck M, Adolfsson J, Stattin P, Zethelius B, Crawley D. Association of Type 2 Diabetes Mellitus and Antidiabetic Medication With Risk of Prostate Cancer: A Population-Based Case-Control Study. BMC Cancer. 2020 Jun 15. Sammanfattning. 
    9. Franck Lissbrant I, Hjälm Eriksson M, Lambe M, Törnblom M, Stattin P. Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden. Scand J Urol. 2020 May 4. Sammanfattning. 
    10. Aly M, Leval A, Schain F, Liwing J, Lawson J,  Vágó E, Nordström T,  Andersson T M-L , Sjöland E, Wang C, Eloranta S, Akre O. Survival in Patients Diagnosed With Castration-Resistant Prostate Cancer: A Population-Based Observational Study in Sweden. Scand J Urol. 2020 April. Sammanfattning. 
    11. Orrason AW, Westerberg M, Garmo H, Franck Lissbrant I, Robinson D, Stattin P. Changes in treatment and mortality in men with locally advanced prostate cancer between 2000-2016. Nationwide, population-based study in Sweden. BJU Int. 2020 Apr 10. Sammanfattning.
    12. Bonde TM, Garmo H, Stattin P, Robinson D. 5α-Reductase inhibitors and risk of prostate cancer death. J Urol. 2020 April 3. Sammanfattning.
    13. Plym A, Clements M, Voss M, Holmberg L, Stattin P, Lambe M. Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study. BMJ Open. 2020 Mar 9. Sammanfattning. 
    14. Beckmann K, Garmo H, Nilsson P, Franck Lissbrant I, Widmark A, Stattin P. Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016. Acta Oncol. 2020 Mar 3. Sammanfattning. 
    15. Mehtälä J, Zong J, Vassilev Z, Brobert G, Gabarró MS, Stattin P, Khanfir H. Overall survival and second primary malignancies in men with metastatic prostate cancer. PloS One, 2020 Feb 21. Sammanfattning. 
    16. Pettersson A, Alm D, Garmo H, Hjelm Eriksson M, Castellanos E, Åström L, Kindblom J, Widmark A, Gunnlaugsson A, Franck Lissbrant I, Nilsson P, Stattin P. Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study. JNCI Cancer Spectr. 2020 Feb 14. Sammanfattning. 
    17. Thomsen F, Westerberg M, Garmo H, Robinson D, Holmberg L, Ulmert D, Stattin P. Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade. Nationwide, population-based register study. PloS One, 2020 Jan 29.  Sammanfattning.
    18. Styrke J, Resare S, Lundström K-J, Masaba P, Lagerros C, Stattin P. Current Routines for Antibiotic Prophylaxis Prior to Transrectal Prostate Biopsy: A National Survey to All Urology Clinics in Sweden. F1000Res. 2020 Jan 28. Sammanfattning.    
    19. Jansson F, Folkvaljon F, Stattin P, Bratt O, Akre O. Risk of Postoperative Upstaging or Upgrading Among Men with Low-Risk Familial Prostate Cancer. J Urol. 2020 Jan 31. Sammanfattning. 
    20. Bratt O, Drevin L, Prütz KG, Carlsson S, Wennberg L, Stattin P. Prostate cancer in kidney transplant recipients – a nationwide register study. BJU Int. 2020 Jan 19. Sammanfattning